CJC + Ipamorelin 10mg

Two Receptors. Different Pathways. Same Signal.

CJC-1295 and Ipamorelin activate growth hormone release through two distinct receptor pathways — the GHRH receptor and the ghrelin receptor. This dual-pathway approach has drawn significant research interest for its ability to produce pulsatile GH patterns without cross-reactivity.

Why Researchers Study It

• CJC-1295 — GHRH receptor activation, pulsatile GH release, no cortisol spike
• Ipamorelin — ghrelin receptor (GHSR1a), selective GH release, no prolactin increase
• Dual-pathway — two receptors, complementary intracellular cascades
• Selectivity — GH release without ACTH, cortisol, or prolactin cross-reactivity

What Makes It Different

Most GH secretagogues activate one receptor. This blend activates two — GHRH and ghrelin — producing a more natural pulsatile pattern that research models suggest may better mimic physiological GH release.

Analytical Documentation

• Purity: Batch-specific Certificate of Analysis (COA) included
• Method: HPLC and/or LC-MS verification
• Storage: Lyophilized — store cool, dry, protected from light